Logo image of BGM

BGM GROUP LTD (BGM) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:BGM - KYG7307E1237 - Common Stock

7.55 USD
-0.01 (-0.13%)
Last: 12/3/2025, 2:44:35 PM

BGM Key Statistics, Chart & Performance

Key Statistics
Market Cap1.23B
Revenue(TTM)26.85M
Net Income(TTM)-2.72M
Shares162.46M
Float51.75M
52 Week High17.17
52 Week Low7
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.28
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO2021-01-12
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


BGM short term performance overview.The bars show the price performance of BGM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30 -40

BGM long term performance overview.The bars show the price performance of BGM in the last 1, 2 and 3 years. 1 year 2 years 3 years -2 -4 -6 -8 -10

The current stock price of BGM is 7.55 USD. In the past month the price decreased by -21.59%. In the past year, price decreased by -11.01%.

BGM GROUP LTD / BGM Daily stock chart

BGM Latest News, Press Relases and Analysis

BGM Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 47.09 978.87B
JNJ JOHNSON & JOHNSON 19.83 495.85B
MRK MERCK & CO. INC. 11.66 254.87B
PFE PFIZER INC 8.03 146.15B
BMY BRISTOL-MYERS SQUIBB CO 7.78 103.89B
ZTS ZOETIS INC 19.38 54.15B
RPRX ROYALTY PHARMA PLC- CL A 9.72 23.07B
VTRS VIATRIS INC 4.66 12.51B
ELAN ELANCO ANIMAL HEALTH INC 23.45 11.19B
CORT CORCEPT THERAPEUTICS INC 94.89 8.78B
AXSM AXSOME THERAPEUTICS INC N/A 7.37B
BLTE BELITE BIO INC - ADR N/A 5.34B

About BGM

Company Profile

BGM logo image BGM Group Ltd. is a holding company, which engages in the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. The company is headquartered in Chengdu, Sichuan and currently employs 323 full-time employees. The company went IPO on 2021-01-12. The firm operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The firm's main brand is Qilian Shan. The firm principally operates its businesses within the domestic market.

Company Info

BGM GROUP LTD

No. 152 Hongliang East 1St Street, No. 1703, Tianfu New District

Chengdu SICHUAN CN

Employees: 323

BGM Company Website

BGM Investor Relations

Phone: 862864775180

BGM GROUP LTD / BGM FAQ

Can you describe the business of BGM GROUP LTD?

BGM Group Ltd. is a holding company, which engages in the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. The company is headquartered in Chengdu, Sichuan and currently employs 323 full-time employees. The company went IPO on 2021-01-12. The firm operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The firm's main brand is Qilian Shan. The firm principally operates its businesses within the domestic market.


What is the stock price of BGM GROUP LTD today?

The current stock price of BGM is 7.55 USD. The price decreased by -0.13% in the last trading session.


What is the dividend status of BGM GROUP LTD?

BGM does not pay a dividend.


What is the ChartMill technical and fundamental rating of BGM stock?

BGM has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Which stock exchange lists BGM stock?

BGM stock is listed on the Nasdaq exchange.


Can you provide the number of employees for BGM GROUP LTD?

BGM GROUP LTD (BGM) currently has 323 employees.


What is the market capitalization of BGM stock?

BGM GROUP LTD (BGM) has a market capitalization of 1.23B USD. This makes BGM a Small Cap stock.


BGM Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

BGM Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to BGM. While BGM seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BGM Financial Highlights

Over the last trailing twelve months BGM reported a non-GAAP Earnings per Share(EPS) of -0.28. The EPS increased by 74.4% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -1.31%
ROE -1.49%
Debt/Equity 0.01
Chartmill High Growth Momentum
EPS Q2Q%-146.9%
Sales Q2Q%13.92%
EPS 1Y (TTM)74.4%
Revenue 1Y (TTM)-10.12%

BGM Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

BGM Ownership

Ownership
Inst Owners0.09%
Ins Owners25.02%
Short Float %0.15%
Short Ratio3.1